Example: Heart Attack

Clinical Trials on Inclusion Body Myositis

Total 31 results

  • NCT01734369
    Recruiting
    Environmental Risk Factors for Myositis in Military Personnel
    Conditions: Dermatomyositis, Adult Polymyositis, Inclusion Body Myositis, Myositis
  • NCT04789070
    Not yet recruiting
    Phase III Trial of Sirolimus in IBM
    Conditions: Inclusion Body Myositis
  • NCT04421677
    Active, not recruiting
    Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis
    Conditions: Inclusion Body Myositis, Sporadic Inclusion Body Myositis
  • NCT04907162
    Recruiting
    Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
    Conditions: Pompe Disease (Late-onset), Myotonic Dystrophy Type 1 (DM1), Myotonic Dystrophy Type 2, Spinal Muscular Atrophy Type 3, Inclusion Body Myositis, Sporadic, Facioscapulohumeral Muscular Dystrophy 1, Healthy
  • NCT00017914
    Recruiting
    Adult and Juvenile Myositis
    Conditions: Dermatomyositis, Polymyositis, Inclusion Body Myositis
  • NCT02753530
    Completed
    Study of Arimoclomol in Inclusion Body Myositis (IBM)
    Conditions: Inclusion Body Myositis
  • NCT04659031
    Not yet recruiting
    A Phase 1 Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)
    Conditions: Inclusion Body Myositis
  • NCT03440034
    Completed
    Study of Pioglitazone in Sporadic Inclusion Body Myositis
    Conditions: Myositis, Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases
  • NCT02250443
    Completed
    Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
    Conditions: Sporadic Inclusion Body Myositis (sIBM)
  • NCT01423110
    Completed
    Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
    Conditions: Sporadic Inclusion Body Myositis
  • NCT04049097
    Enrolling by invitation
    Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
    Conditions: Inclusion Body Myositis
  • NCT03633318
    Completed
    Establishing Muscle Impedance Parameters With Electrical Impedance Myography
    Conditions: IBM, Inclusion Body Myositis
  • NCT03710941
    Withdrawn
    Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
    Conditions: Sporadic Inclusion Body Myositis
  • NCT02481453
    Completed
    Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis
    Conditions: Inclusion Body Myositis (IBM)
  • NCT02573467
    Completed
    An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203
    Conditions: Sporadic Inclusion Body Myositis
  • NCT01432613
    Completed
    Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
    Conditions: Myositis, Polymyositis, Dermatomyositis, Myositis, Inclusion Body
  • NCT03299335
    Unknown status
    Molecular Profile of the Evolution of Inclusion Body Myositis
    Conditions: Inclusion Body Myositis
  • NCT01519349
    Completed
    Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
    Conditions: Becker Muscular Dystrophy, Sporadic Inclusion Body Myositis
  • NCT01925209
    Completed
    Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
    Conditions: Sporadic Inclusion Body Myositis
  • NCT00030212
    Completed
    Immune Abnormalities in Sporadic Inclusion Body Myositis
    Conditions: Sporadic, Inclusion Body, Myositis
  • NCT02483845
    Unknown status
    Natalizumab in Inclusion Body Myositis (IBM)
    Conditions: Inclusion Body Myositis (IBM)
  • NCT00769860
    Completed
    Arimoclomol in Sporadic Inclusion Body Myositis
    Conditions: Inclusion Body Myositis
  • NCT02735447
    Unknown status
    Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study
    Conditions: Sporadic Inclusion Body Myositis
  • NCT02317094
    Completed
    Blood-flow Restricted Exercise in Inclusion Body Myositis
    Conditions: Sporadic Inclusion Body Myositis
  • NCT01902940
    Completed
    Natural History in CCFDN and IBM Syndromes
    Conditions: Inclusion Body Myositis, Sporadic, Inclusion Body Myopathy, Autosomal-recessive, Inclusion Body Myopathy, Autosomal-dominant, Congenital Cataracts, Facial Dysmorphism, And Neuropathy
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations